Levomepromazine for schizophrenia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Levomepromazine for schizophrenia

Published:2010-10-06 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Sivaraman Parthipan¹,Rattehalli Ranganath D²,Jayaram Mahesh B³

Affiliation:

1. Sheffield Health and Social Care Foundation NHS Trust; East Glade Centre; Sheffield South Yorkshire UK S12 4QN

2. Assertive Outreach Team; 22 The Auenue York UK YO30 6AS

3. Leeds Partnership Foundation NHS Trust; CMHT; Aire Court Lingwell Grove Leeds UK LS10 4BS

Publisher

Wiley

Subject

Pharmacology (medical)

Reference72 articles.

1. Ergebnisse eines Doppelblindversuches von HF 1854 (8-Chlor-11-(4 methyl-1-piperazinyl)-5H-dibenzo (b,e) (1,4) diazepin) im Vergleich zu Levomepromazin;Angst;Pharmakopsychiatrie und Neuropsychopharmakologie,1971

2. Assessing a new phenothiazine;Baker;Journal of Mental Science,1958

3. Antipsychotic and anxiolytic properties of risperidone, haloperidol, and methotrimeprazine in schizophrenic patients;Blin;Journal of Clinical Psychopharmacology,1996

4. Anxiolytic profiles of levomepromazine, haloperidol and risperidone in 62 schizophrenic patients;Blin;Clinical Pharmacology and Therapeutics,1992

5. Anxiolytic profiles of levomepromazine, haloperidol, and risperidone in 62 schizophrenic patients;Blin;Psychopharmacology,1992

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low-Potency Antipsychotics: Levomepromazine, Melperon, and Pipamperone;NeuroPsychopharmacotherapy;2022

2. Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2;Frontiers in Pharmacology;2021-01-25

3. Low-Potency Antipsychotics: Levomepromazine, Melperon, and Pipamperone;NeuroPsychopharmacotherapy;2021

4. Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2;2020-08-18

5. Antipsychotic drugs and sudden cardiac death: A literature review of the challenges in the prediction, management, and future steps;Psychiatry Research;2019-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3